Featured Cancer Videos |view more

Heated Intraperitoneal Chemotherapy (HIPEC) for Rare, Aggressive Cancers at Penn Medicine

HIPEC is one of the most innovative treatments available today for complex cancers. Associate Professor of Surgery at the Hospital of the University of Pennsylvania and a surgical oncologist, Dr. Giorgos Karakousis specializes in heated ...

Video

Dr. Ronny Drapkin Reviews Advances in Ovarian Cancer Treatment Research

Among the top ovarian cancer researchers in the country, Penn Medicine Gynecologic Pathologist Ronny Drapkin, MD, PhD, is a passionate advocate of pioneering scientific research to detect and treat ovarian cancer.

Video

A Seat at the Table: Removing Barriers and Bias for Women in Oncology | Penn Medicine

In Fall 2019, Penn Medicine’s Abramson Cancer Center hosted its inaugural Women in Oncology event, A Seat at the Table.

Video

Why Are Brain Tumor Second Opinions Important? — the Penn Brain Tumor Center

As M. Sean Grady, Chairman, Department of Neurosurgery, explains, when patients are faced with a malignant brain tumor, a second opinion from the specialists at the Penn Brain Tumor Center can confirm or clarify the initial diagnosis and, ...

Video

Clinical Trials and Research at the Penn Brain Tumor Center

The Penn Brain Tumor Center offers patients access to innovative advances in treatment -- including immunotherapy -- through personalized clinical trials.

Video

How a Neuro-Oncology Nurse Navigator Supports Patients During Brain Tumor Treatment | The Penn Brain Tumor Center

With specialized training and knowledge of cancer diagnoses, treatments and health system operations, Penn Neuro-Onc Nurse Navigators act as a patient’s primary contact during their course of care.

Featured Articles & Documents |view more

Document

Hepatic Arterial Infusion Chemotherapy for Colorectal Liver Metastases

Surgeons and oncologists within the Department of Surgery at Penn Medicine are using adjuvant hepatic artery infusion chemotherapy with systemic chemotherapy to prevent recurrence in patients with resected colorectal liver metastases...

Document

Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Investigators in the Division of Gynecologic Oncology at Penn Medicine are conducting a clinical trial to investigate combination therapy with olaparib and AZD6738 in women with high grade serous ovarian or primary peritoneal and/or fallopian tube cancer.